PL2874608T4 - Suche granulaty mezoporowatych proszków krzemionkowych - Google Patents

Suche granulaty mezoporowatych proszków krzemionkowych

Info

Publication number
PL2874608T4
PL2874608T4 PL13747654T PL13747654T PL2874608T4 PL 2874608 T4 PL2874608 T4 PL 2874608T4 PL 13747654 T PL13747654 T PL 13747654T PL 13747654 T PL13747654 T PL 13747654T PL 2874608 T4 PL2874608 T4 PL 2874608T4
Authority
PL
Poland
Prior art keywords
mesoporous silica
silica powders
dry granulates
granulates
dry
Prior art date
Application number
PL13747654T
Other languages
English (en)
Other versions
PL2874608T3 (pl
Inventor
Michiel VAN SPEYBROEK
Loes VERHEYDEN
Original Assignee
Formac Pharmaceuticals N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formac Pharmaceuticals N.V. filed Critical Formac Pharmaceuticals N.V.
Publication of PL2874608T3 publication Critical patent/PL2874608T3/pl
Publication of PL2874608T4 publication Critical patent/PL2874608T4/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
PL13747654T 2012-07-20 2013-07-19 Suche granulaty mezoporowatych proszków krzemionkowych PL2874608T4 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1212866.6A GB201212866D0 (en) 2012-07-20 2012-07-20 Dry granulates of mesoporous silica powders
EP13747654.5A EP2874608B1 (en) 2012-07-20 2013-07-19 Dry granulates of mesoporous silica powders
PCT/EP2013/065258 WO2014013044A1 (en) 2012-07-20 2013-07-19 Dry granulates of mesoporous silica powders

Publications (2)

Publication Number Publication Date
PL2874608T3 PL2874608T3 (pl) 2021-08-02
PL2874608T4 true PL2874608T4 (pl) 2021-08-02

Family

ID=46881657

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13747654T PL2874608T4 (pl) 2012-07-20 2013-07-19 Suche granulaty mezoporowatych proszków krzemionkowych

Country Status (6)

Country Link
US (1) US20150209285A1 (pl)
EP (1) EP2874608B1 (pl)
ES (1) ES2821802T3 (pl)
GB (1) GB201212866D0 (pl)
PL (1) PL2874608T4 (pl)
WO (1) WO2014013044A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013343565B2 (en) 2012-11-06 2018-07-26 Sigrid Therapeutics Ab A porous silica material for use as a pharmaceutical or dietary active ingredient
CN103933000B (zh) * 2014-05-06 2021-11-12 山东新时代药业有限公司 一种阿齐沙坦片剂及其制备方法
GB201502073D0 (en) 2015-02-09 2015-03-25 Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd HDEG technology
AU2018262708B2 (en) * 2017-05-04 2021-06-03 Nanologica Ab A process for manufacturing porous silica particles loaded with at least one bioactive compound adapted for lung, nasal, sublingual and/or pharyngeal delivery
US12459829B2 (en) 2018-11-07 2025-11-04 Disruptive Pharma Ab Amorphous active pharmaceutical ingredients comprising substantially amorphous mesoporous magnesium carbonate
WO2021069074A1 (en) * 2019-10-10 2021-04-15 Sil'innov Srcl Silica with ultra-fast dissolution properties
CN117957213A (zh) * 2021-07-20 2024-04-30 矿物疗法公司 包括经二取代的1,2,4-三嗪化合物的盐的可溶性药物组合物
CN116942743B (zh) * 2023-09-06 2024-08-16 通化万通药业股份有限公司 一种感冒清片的制备方法及其产品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100715296B1 (ko) * 2003-07-29 2007-05-08 가부시끼가이샤 도꾸야마 중세공성 실리카 미립자 및 그 제조 방법
GB0420016D0 (en) * 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
US8871273B2 (en) * 2005-02-25 2014-10-28 Takeda Pharmaceutical Company Limited Method for producing granules
US8048413B2 (en) * 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
US20100160442A1 (en) * 2006-07-18 2010-06-24 Ossovskaya Valeria S Formulations for cancer treatment
JP2012506904A (ja) * 2008-10-28 2012-03-22 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ 難水溶性成分のためのメソ多孔性材料賦形剤
US20130243833A1 (en) * 2010-11-29 2013-09-19 Formac Pharmaceuticals N.V. Compressed formulations of ordered mesoporous silicas

Also Published As

Publication number Publication date
US20150209285A1 (en) 2015-07-30
WO2014013044A1 (en) 2014-01-23
ES2821802T3 (es) 2021-04-27
GB201212866D0 (en) 2012-09-05
PL2874608T3 (pl) 2021-08-02
EP2874608A1 (en) 2015-05-27
EP2874608B1 (en) 2020-07-01

Similar Documents

Publication Publication Date Title
ZA201501847B (en) Formulations of enzalutamide
EP2802534A4 (en) INTRODUCTION OF MESOPOROSITY IN POOR SILICA ZEOLITES
PL2874608T3 (pl) Suche granulaty mezoporowatych proszków krzemionkowych
EP2829873A4 (en) POROUS SILICONE POWDER
ZA201406082B (en) Use of ccr3-inhibitors
EP4342536C0 (en) BROMOCRIPTINE FORMULATIONS
PL2641941T3 (pl) Wytwarzanie pigmentów
EP2853105A4 (en) CONTROLLED SEARCH
SG11201504134SA (en) External preparation
GB201222832D0 (en) Manufacture of hollow parts
GB201501016D0 (en) Preparation of 18F-fluciclovine
EP4274235C0 (en) VECTOR QUANTIFIER
ZA201502350B (en) Solid form of hihydro-pyrido-oxazine derivative
ZA201500488B (en) Manufacture of wheels
ZA201405824B (en) Process for the preparation of substituted phenylpropanones
HUE036665T2 (hu) Dihidro-pirido-oxazin származék szilárd formái
TWM433525U (en) Structure of calorifier
GB201212160D0 (en) Cyclone
GB201200029D0 (en) Secure as you go
GB201222952D0 (en) Treatent of cancer
AU2012901311A0 (en) Provision of entertainment
AU2012900977A0 (en) Improvements to the manufacture of biochar-coke